EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access

The Ethics of Leveraging Routinely Collected Patient Data for AI Development: Mixed Methods Study

Die Ethik der Nutzung routinemäßig erhobener Patientendaten für die KI-Entwicklung: Mixed-Methods-Studie

Menno T Maris, Joanna E Klopotowska, Ronald Cornet, Mariëtte A Van den Hoven, Joris E Lieverse, Daniel Fernández-Llaneza, Marieke A R Bak, LEAPfROG Consortium

Journal of Medical Internet Research · 02.03.2026 · 28 · e79863-e79863

DOI: 10.2196/79863 ↗

Auf einen Blick

Eine Mixed-Methods-Studie untersuchte ethische Herausforderungen bei der Nutzung von EHR-Daten für KI-Entwicklung. Im Fokus standen Datenschutz, Vertrauen, Repräsentation und die verantwortliche Einbindung in die Praxis.

Fragestellung

Welche ethischen Herausforderungen entstehen an der Schnittstelle von EHR-Daten und KI-Entwicklung, und welche praxisnahen Empfehlungen lassen sich ableiten?

Methode

Mixed-Methods-Design mit Scoping-Review und 2 Stakeholder-Workshops; 25 relevante Publikationen von 2014 bis 2024; Workshops mit 17 und 13 Teilnehmenden.

Ergebnisse

Es wurden 4 Themen identifiziert: Datenschutz/Transparenz/Einwilligung, öffentliches Vertrauen/Regulierung, faire Repräsentation/Generalisierbarkeit und verantwortliche KI-Integration in die Praxis.

Einschränkungen

Die Analyse stützt sich auf Literatur und Stakeholder-Perspektiven; konkrete methodische Einschränkungen werden im Abstract nicht genannt.

Schlussfolgerung der Autor:innen

Verantwortliche KI-Entwicklung erfordert Aufmerksamkeit für Entstehung, Interpretation und Governance von EHR-Daten im Praxiszusammenhang; technische Lösungen oder reine Top-down-Regulierung reichen nicht aus.

Kernaussagen

  • 4 Themen prägten die ethische Analyse von EHR-Daten und KI.
  • Wesentlich waren Datenschutz, Vertrauen, Repräsentation und Praxisintegration.
  • Die Autor:innen betonen stakeholder- und kontextsensitives Vorgehen.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift Journal of Medical Internet Research, online erschienen am 02.03.2026. Verfasst von Menno T Maris und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ethics, Law and Humanities, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands, 31 (020) 566 91…. Hauptthemen laut MEDLINE: Artificial Intelligence, Electronic Health Records. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Electronic health record (EHR) data, a key form of routinely collected patient data, offer great potential for medical research and the development of artificial intelligence (AI) tools. However, because these data are primarily gathered for health care rather than research, it often lacks the quality needed for AI training, raising both methodological and ethical concerns. While previous studies have reviewed the ethical implications of both routinely collected patient data and AI separately, their intersection, where AI is applied to such data, remains largely unexplored.

Objective

This study aimed to examine the ethical challenges that arise at the intersection of EHR data and AI development and to derive practice-oriented recommendations using the Dutch LEAPfROG (Leveraging Real-World Data to Optimize Pharmacotherapy Outcomes in Multimorbid Patients Using Machine Learning and Knowledge Representation Methods) project as a guiding case.

Methods

We used a mixed methods design combining a scoping literature review with a systematic search and 2 stakeholder workshops structured by the guidance ethics approach, reflecting a staged and iterative process aligned with the LEAPfROG project’s development phases. The review identified 25 relevant publications from 2014 to 2024. The workshops, conducted with 17 and 13 participants respectively, included patients, clinicians, ethicists, data officers, and AI developers. Both workshops used dialogue to identify ethical values, impacts, and action points, focusing on a case study of drug-induced acute kidney injury.

Results

The analysis highlighted four major themes: (1) data privacy, transparency, and consent, including challenges of meaningful consent and risks of reidentification; (2) public trust and regulatory challenges, such as fragmented oversight and inconsistent governance; (3) fair representation and model generalizability, where incomplete or biased data may perpetuate health inequities; and (4) responsible AI integration in clinical practice, including concerns about clinical tropism, administrative burden, and the risk of overreliance on AI outputs. Both literature and stakeholder perspectives underscore the risk of decontextualization when EHR data are reused and emphasize the importance of clearly defining the purpose of data reuse to ensure real-world applicability and foster trust.

Conclusions

Responsible AI development requires explicit attention to how EHR data are produced, interpreted, and governed in practice, recognizing that data quality and meaning are shaped by the clinical, institutional, and social contexts in which they originate. Technical solutions or top-down regulation alone are insufficient. Instead, stakeholder-led and context-sensitive approaches are needed to define the purposes, risks, and benefits of medical AI. Grounded in the realities of health care practice and in the perspectives of patients, clinicians, and data custodians, these approaches can strengthen transparency, fairness, and clinical relevance, ensuring that EHR data are used ethically and effectively to support equitable and trustworthy AI innovation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceElectronic Health RecordsHumans

Stichwörter der Autor:innen

artificial intelligenceethicsmedical informaticspharmacotherapyroutinely collected health datastakeholder participation

Autor:innen und Institutionen

  • Department of Ethics, Law and Humanities, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands, 31 (020) 566 9111.
  • Amsterdam Public Health Institute, Amsterdam, The Netherlands.
  • Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Ethics, Law and Humanities, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Institute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • See Acknowledgments.

Zitieren

APA

Maris, M. T., Klopotowska, J. E., Cornet, R., Van den Hoven, M. A., Lieverse, J. E., Fernández-Llaneza, D., Bak, M. A. R., & LEAPfROG Consortium (2026). The Ethics of Leveraging Routinely Collected Patient Data for AI Development: Mixed Methods Study. Journal of Medical Internet Research, 28, e79863-e79863. https://doi.org/10.2196/79863

Vancouver

Maris MT, Klopotowska JE, Cornet R, Van den Hoven MA, Lieverse JE, Fernández-Llaneza D, et al. The Ethics of Leveraging Routinely Collected Patient Data for AI Development: Mixed Methods Study. Journal of Medical Internet Research. 2026;28:e79863-e79863. doi:10.2196/79863

BibTeX
@article{Maris2026,
  author = {Maris, Menno T and Klopotowska, Joanna E and Cornet, Ronald and Van den Hoven, Mariëtte A and Lieverse, Joris E and Fernández-Llaneza, Daniel and Bak, Marieke A R and LEAPfROG Consortium, LEAPfROG Consortium},
  title = {The Ethics of Leveraging Routinely Collected Patient Data for AI Development: Mixed Methods Study},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e79863--e79863},
  doi = {10.2196/79863}
}
Kostenlos starten →